343 related articles for article (PubMed ID: 28825595)
21. SETD2: an epigenetic modifier with tumor suppressor functionality.
Li J; Duns G; Westers H; Sijmons R; van den Berg A; Kok K
Oncotarget; 2016 Aug; 7(31):50719-50734. PubMed ID: 27191891
[TBL] [Abstract][Full Text] [Related]
22. The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice.
Zuo X; Rong B; Li L; Lv R; Lan F; Tong MH
J Biol Chem; 2018 Jun; 293(24):9188-9197. PubMed ID: 29716999
[TBL] [Abstract][Full Text] [Related]
23. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.
Li H; An J; Wu M; Zheng Q; Gui X; Li T; Pu H; Lu D
Oncotarget; 2015 Sep; 6(29):27847-64. PubMed ID: 26172293
[TBL] [Abstract][Full Text] [Related]
24. SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle.
Gautam D; Johnson BA; Mac M; Moody CA
PLoS Pathog; 2018 Oct; 14(10):e1007367. PubMed ID: 30312361
[TBL] [Abstract][Full Text] [Related]
25. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
26. H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells.
Wang L; Niu N; Li L; Shao R; Ouyang H; Zou W
PLoS Biol; 2018 Nov; 16(11):e2006522. PubMed ID: 30422989
[TBL] [Abstract][Full Text] [Related]
27. The histone methyltransferase Setd2 is indispensable for V(D)J recombination.
Ji Z; Sheng Y; Miao J; Li X; Zhao H; Wang J; Cheng C; Wang X; Liu K; Zhang K; Xu L; Yao J; Shen L; Hou J; Zhou W; Sun J; Li L; Gao WQ; Zhu HH
Nat Commun; 2019 Jul; 10(1):3353. PubMed ID: 31350389
[TBL] [Abstract][Full Text] [Related]
28. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
[TBL] [Abstract][Full Text] [Related]
29. Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
Skucha A; Ebner J; Grebien F
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818762
[TBL] [Abstract][Full Text] [Related]
30. SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12.
González-Rodríguez P; Engskog-Vlachos P; Zhang H; Murgoci AN; Zerdes I; Joseph B
Cell Death Dis; 2020 Jan; 11(1):69. PubMed ID: 31988284
[TBL] [Abstract][Full Text] [Related]
31.
Zhou Y; Yan X; Feng X; Bu J; Dong Y; Lin P; Hayashi Y; Huang R; Olsson A; Andreassen PR; Grimes HL; Wang QF; Cheng T; Xiao Z; Jin J; Huang G
Haematologica; 2018 Jul; 103(7):1110-1123. PubMed ID: 29650642
[No Abstract] [Full Text] [Related]
32. Setd2 supports GATA3
Ding Z; Cai T; Tang J; Sun H; Qi X; Zhang Y; Ji Y; Yuan L; Chang H; Ma Y; Zhou H; Li L; Sheng H; Qiu J
Nat Commun; 2022 Dec; 13(1):7468. PubMed ID: 36463230
[TBL] [Abstract][Full Text] [Related]
33. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling.
Oudhoff MJ; Braam MJS; Freeman SA; Wong D; Rattray DG; Wang J; Antignano F; Snyder K; Refaeli I; Hughes MR; McNagny KM; Gold MR; Arrowsmith CH; Sato T; Rossi FMV; Tatlock JH; Owen DR; Brown PJ; Zaph C
Dev Cell; 2016 Apr; 37(1):47-57. PubMed ID: 27046831
[TBL] [Abstract][Full Text] [Related]
34. PAF-Myc-Controlled Cell Stemness Is Required for Intestinal Regeneration and Tumorigenesis.
Kim MJ; Xia B; Suh HN; Lee SH; Jun S; Lien EM; Zhang J; Chen K; Park JI
Dev Cell; 2018 Mar; 44(5):582-596.e4. PubMed ID: 29533773
[TBL] [Abstract][Full Text] [Related]
35. Deficiency of Histone Methyltransferase SET Domain-Containing 2 in Liver Leads to Abnormal Lipid Metabolism and HCC.
Li XJ; Li QL; Ju LG; Zhao C; Zhao LS; Du JW; Wang Y; Zheng L; Song BL; Li LY; Li L; Wu M
Hepatology; 2021 May; 73(5):1797-1815. PubMed ID: 33058300
[TBL] [Abstract][Full Text] [Related]
36. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
[TBL] [Abstract][Full Text] [Related]
37. Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts.
Yi X; Tao Y; Lin X; Dai Y; Yang T; Yue X; Jiang X; Li X; Jiang DS; Andrade KC; Chang J
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):697-707. PubMed ID: 28130125
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase.
Lam UTF; Chen ES
Int J Biochem Cell Biol; 2022 Mar; 144():106155. PubMed ID: 34990836
[TBL] [Abstract][Full Text] [Related]
39. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
[TBL] [Abstract][Full Text] [Related]
40. Histone methyltransferase SETD2 is required for meiotic maturation in mouse oocyte.
Li C; Diao F; Qiu D; Jiang M; Li X; Han L; Li L; Hou X; Ge J; Ou X; Liu J; Wang Q
J Cell Physiol; 2018 Jan; 234(1):661-668. PubMed ID: 30078214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
